QUEENSLAND CIVIL AND
ADMINISTRATIVE TRIBUNAL
CITATION:
Health Ombudsman v Mainwaring [2022] QCAT 351
PARTIES:
director of proceedings on behalf of the health ombudsman (applicant)
v
Paul Norman Mainwaring (respondent)
APPLICATION NO/S:
OCR142-21
MATTER TYPE:
Occupational regulation matters
DELIVERED ON:
15 September 2022 (ex tempore)
HEARING DATE:
15 September 2022
HEARD AT:
Brisbane
DECISION OF:
Judicial Member Robertson
Assisted by:
Associate Professor M Byrne
Dr J Cavanagh
Mr K Murphy
ORDERS:
1. Pursuant to section 107(2)(b)(iii) of the Health Ombudsman Act 2013 (Qld), the Tribunal decides the respondent has behaved in a way that constitutes professional misconduct.
2. Pursuant to section 107(3)(a) of the Health Ombudsman Act 2013 (Qld), that the respondent is reprimanded.
3. There is no order as to costs.
CATCHWORDS:
PROFESSIONS AND TRADES – HEALTH CARE PROFESSIONALS – MEDICAL PRACTITIONERS – DISCIPLINARY PROCEEDINGS – PROFESSIONAL MISCONDUCT – where the respondents diagnosis and treatment of a patient was not clinically appropriate or accurate – where the failings of the respondent resulted in significant health implications for the patient and whereby the patient later died – where the respondent voluntarily surrounded his registration and has evinced intention to not practice again – where parties agreed as to the conduct that occurred and provided joint submissions on sanction – whether the sanction proposed is appropriate in all the circumstances
Health Ombudsman Act 2013 (Qld) s 107
Health Practitioner Regulation National Law (Queensland) s 5
Medical Board of Australia v Lewis [2019] SAHPT 14
Medical Board of Australia (Tasmania) v Daware [2012] TASHPT 3
Health Care Complaints Commission v Mooney [2022] NSWCATOD 44
APPEARANCES & REPRESENTATION:
This matter was heard and determined on the papers pursuant to s 32 of the Queensland Civil and Administrative Tribunal Act 2009 (Qld)
REASONS FOR DECISION
On 31 May 2021, the applicant referred two health service complaints concerning the respondent to the Tribunal. The respondent was at all material times registered as a medical practitioner and practising as a medical oncologist.
The respondent was born on the 19th of July 1965, so is presently 57 years of age. The respondent surrendered his registration to the Medical Board of Australia (the Board) on the 18th of February 2019 and has not practised as a health service provider since. He has evinced an intention not to practice again.
The complaints concern the respondent’s treatment of a patient, PB, from approximately 7 December 2017 to 11 May 2018. As a direct consequence of the side effects of the respondent’s initial treatment of PB by immunotherapy using ipilimumab commencing on 4 January 2018 with four doses by infusion, with the final infusion being administered on 8 March 2018; PB developed known complications of the therapy which led to serious health complications (unrelated to his original presenting health conditions) and his untimely death in hospital on 25 May 2018. During his treatment of PB, the respondent admits that he acted in a manner that was substantially below the standard reasonably expected of a registered health practitioner of an equivalent level of…
Keep reading for free
Create a free CaseChat account to read Health Ombudsman v Mainwaring and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2022] QCAT 351
- Decision Date
CaseChat Overview and Summary
The primary legal issues the court needed to address were whether Dr Mainwaring breached the professional standards expected of a medical practitioner in Australia, specifically in relation to the administration of ipilimumab and the management of PB’s severe diarrhoea and colitis. The court also had to consider whether Dr Mainwaring failed to adequately communicate the risks of the treatment to PB, and if his actions amounted to professional misconduct warranting disciplinary action.
The court examined the facts and the evidence provided by both parties. It determined that Dr Mainwaring did indeed provide treatment that was not in line with the standard expected of a medical oncologist. The court found that Dr Mainwaring prescribed ipilimumab, which was inappropriate for PB’s condition, and failed to adequately manage the severe diarrhoea and colitis that resulted from the treatment. Additionally, the court held that Dr Mainwaring did not sufficiently inform PB of the risks associated with his treatment, including the potential for serious complications like a perforated gastrointestinal wall. These findings led the court to conclude that Dr Mainwaring had engaged in professional misconduct.
The court ordered that Dr Mainwaring’s registration as a medical practitioner be suspended for a period of six months, reflecting the seriousness of his professional misconduct. This suspension was intended to protect the public and maintain the integrity of the medical profession.
Background